Novel 3-pyridinecarbonitriles incorporating sulfonamide moieties as anti-breast cancer agents
- Authors: Ghorab M.M.1,2, Alsaid M.S.1
-
Affiliations:
- Pharmacognosy Department, College of Pharmacy
- Department of Drug Radiation Research
- Issue: Vol 42, No 4 (2016)
- Pages: 441-448
- Section: Article
- URL: https://journals.rcsi.science/1068-1620/article/view/228059
- DOI: https://doi.org/10.1134/S1068162016040087
- ID: 228059
Cite item
Abstract
A novel series of 3-pyridinecarbonitrile derivatives incorporating sulfonamide moieties and sulfonyl derivatives was synthesized using 2-chloro-6-methylnicotinonitrile as a strategic starting material. The structures of the synthesized compounds were elucidated on the basis of elemental analysis, IR, 1H NMR, 13C NMR, and mass spectral data. All the prepared compounds were evaluated for their in vitro anticancer activity against breast cancer cell line (MCF-7). Most of the compounds showed good to moderate activity, higher than that of the reference drug doxorubicin. Two compounds showed the same activity as doxorubicin, while three compounds exhibited remarkable activity.
About the authors
Mostafa M. Ghorab
Pharmacognosy Department, College of Pharmacy; Department of Drug Radiation Research
Author for correspondence.
Email: mmsghorab@yahoo.com
Saudi Arabia, Riyadh, 11451; Nasr City, Cairo, 113701
Mansour S. Alsaid
Pharmacognosy Department, College of Pharmacy
Email: mmsghorab@yahoo.com
Saudi Arabia, Riyadh, 11451
Supplementary files
